Similar articles for PMID: 31114360

Year	Number of Results
1986	1
1988	1
1989	5
1990	4
1991	9
1992	6
1993	9
1994	9
1995	6
1996	3
1997	2
1998	2
1999	3
2001	1
2002	1
2003	3
2004	1
2006	1
2008	1
2009	1
2010	1
2011	2
2012	2
2013	1
2015	2
2016	4
2017	2
2018	2
2019	6
2020	1
2021	1
2024	0

1

Assessment of the presence and anti-tumor potential of tumor-infiltrating lymphocytes in patients with acute myeloid leukemia.

Wei L, Wang Z, Zhang Z, Li Y, Fan S, Zhao Y, Liu Z, Ye X, Zhang F, Yu Y, Liu X, Cao F, Zhou J. Wei L, et al. Cancer Manag Res. 2019 Apr 12;11:3187-3196. doi: 10.2147/CMAR.S199817. eCollection 2019. Cancer Manag Res. 2019. PMID: 31114360 Free PMC article.

2

Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo.

Steger GG, Pierce WC, Figlin R, Czernin J, Kaboo R, DeKernion JB, Okarma T, Belldegrun A. Steger GG, et al. Clin Immunol Immunopathol. 1994 Aug;72(2):237-47. doi: 10.1006/clin.1994.1137. Clin Immunol Immunopathol. 1994. PMID: 8050198

3

Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients' bone marrow.

Cao H, Kim DH, Howard A, Moz H, Wasnik S, Baylink DJ, Chen CS, Reeves ME, Mirshahidi S, Xiao J, Francis O, Marcucci G, Xu Y. Cao H, et al. Neoplasia. 2021 Dec;23(12):1252-1260. doi: 10.1016/j.neo.2021.11.003. Epub 2021 Nov 11. Neoplasia. 2021. PMID: 34775232 Free PMC article.

4

Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation.

Finke JH, Rayman P, Hart L, Alexander JP, Edinger MG, Tubbs RR, Klein E, Tuason L, Bukowski RM. Finke JH, et al. J Immunother Emphasis Tumor Immunol. 1994 Feb;15(2):91-104. doi: 10.1097/00002371-199402000-00002. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7907918

5

Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.

Klöß S, Oberschmidt O, Morgan M, Dahlke J, Arseniev L, Huppert V, Granzin M, Gardlowski T, Matthies N, Soltenborn S, Schambach A, Koehl U. Klöß S, et al. Hum Gene Ther. 2017 Oct;28(10):897-913. doi: 10.1089/hum.2017.157. Epub 2017 Aug 15. Hum Gene Ther. 2017. PMID: 28810809

6

Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.

Baxevanis CN, Dedoussis GV, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M. Baxevanis CN, et al. Cancer. 1994 Aug 15;74(4):1275-82. doi: 10.1002/1097-0142(19940815)74:4<1275::aid-cncr2820740416>3.0.co;2-q. Cancer. 1994. PMID: 7914469

7

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.

Junker N, Andersen MH, Wenandy L, Dombernowsky SL, Kiss K, Sørensen CH, Therkildsen MH, Von Buchwald C, Andersen E, Straten PT, Svane IM. Junker N, et al. Cytotherapy. 2011 Aug;13(7):822-34. doi: 10.3109/14653249.2011.563291. Epub 2011 Mar 24. Cytotherapy. 2011. PMID: 21428850

8

Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.

Goedegebuure PS, Douville LM, Li H, Richmond GC, Schoof DD, Scavone M, Eberlein TJ. Goedegebuure PS, et al. J Clin Oncol. 1995 Aug;13(8):1939-49. doi: 10.1200/JCO.1995.13.8.1939. J Clin Oncol. 1995. PMID: 7636534 Clinical Trial.

9

Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.

Santin AD, Bellone S, Palmieri M, Bossini B, Roman JJ, Cannon MJ, Bignotti E, Canè S, Pecorelli S. Santin AD, et al. Gynecol Oncol. 2003 May;89(2):271-80. doi: 10.1016/s0090-8258(03)00083-0. Gynecol Oncol. 2003. PMID: 12713991 Clinical Trial.

10

Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.

Wong JT, Pinto CE, Gifford JD, Kurnick JT, Kradin RL. Wong JT, et al. J Immunol. 1989 Nov 15;143(10):3404-11. J Immunol. 1989. PMID: 2509557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

90 results

Results by year